Healthcare

Global Hemophilia Drugs Market Professional Survey Report 2017

  • QYR1615611
  • 122 Pages
  • September 2017
  • Healthcare
Download Sample    Get Discount   
 
This report studies Hemophilia Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

Baxalta

Bayer

CSL Behring

Novo Nordisk

Pfizer

Roche

Alnylam Pharmaceuticals

Amarna Therapeutics

Asklepios BioPharmaceutical

Biogen

BioMarin

Catalyst Bioscience

Chiesi Farmaceutici

Dimension Therapeutics

Emergent BioSolutions

Grifols, Kedrion Biopharma

Octapharma

rEVO Biologics

OPKO Biologics

Sangamo Biosciences

Spark Therapeutics

Swedish Orphan Biovitrum

UniQure Biopharma.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Hemophilia A

Hemophilia B

Hemophilia C

By Application, the market can be split into

Clinic

Hospital

By Regions, this report covers (we can add the regions/countries as you want)

North America

China

Europe

Southeast Asia

Japan

India

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Hemophilia Drugs Market Professional Survey Report 2017

1 Industry Overview of Hemophilia Drugs

1.1 Definition and Specifications of Hemophilia Drugs

1.1.1 Definition of Hemophilia Drugs

1.1.2 Specifications of Hemophilia Drugs

1.2 Classification of Hemophilia Drugs

1.2.1 Hemophilia A

1.2.2 Hemophilia B

1.2.3 Hemophilia C

1.3 Applications of Hemophilia Drugs

1.3.1 Clinic

1.3.2 Hospital

1.3.3 Application 3

1.4 Market Segment by Regions

1.4.1 North America

1.4.2 China

1.4.3 Europe

1.4.4 Southeast Asia

1.4.5 Japan

1.4.6 India

2 Manufacturing Cost Structure Analysis of Hemophilia Drugs

2.1 Raw Material and Suppliers

2.2 Manufacturing Cost Structure Analysis of Hemophilia Drugs

2.3 Manufacturing Process Analysis of Hemophilia Drugs

2.4 Industry Chain Structure of Hemophilia Drugs

3 Technical Data and Manufacturing Plants Analysis of Hemophilia Drugs

3.1 Capacity and Commercial Production Date of Global Hemophilia Drugs Major Manufacturers in 2016

3.2 Manufacturing Plants Distribution of Global Hemophilia Drugs Major Manufacturers in 2016

3.3 R&D Status and Technology Source of Global Hemophilia Drugs Major Manufacturers in 2016

3.4 Raw Materials Sources Analysis of Global Hemophilia Drugs Major Manufacturers in 2016

4 Global Hemophilia Drugs Overall Market Overview

4.1 2012-2017E Overall Market Analysis

4.2 Capacity Analysis

4.2.1 2012-2017E Global Hemophilia Drugs Capacity and Growth Rate Analysis

4.2.2 2016 Hemophilia Drugs Capacity Analysis (Company Segment)

4.3 Sales Analysis

4.3.1 2012-2017E Global Hemophilia Drugs Sales and Growth Rate Analysis

4.3.2 2016 Hemophilia Drugs Sales Analysis (Company Segment)

4.4 Sales Price Analysis

4.4.1 2012-2017E Global Hemophilia Drugs Sales Price

4.4.2 2016 Hemophilia Drugs Sales Price Analysis (Company Segment)

5 Hemophilia Drugs Regional Market Analysis

5.1 North America Hemophilia Drugs Market Analysis

5.1.1 North America Hemophilia Drugs Market Overview

5.1.2 North America 2012-2017E Hemophilia Drugs Local Supply, Import, Export, Local Consumption Analysis

5.1.3 North America 2012-2017E Hemophilia Drugs Sales Price Analysis

5.1.4 North America 2016 Hemophilia Drugs Market Share Analysis

5.2 China Hemophilia Drugs Market Analysis

5.2.1 China Hemophilia Drugs Market Overview

5.2.2 China 2012-2017E Hemophilia Drugs Local Supply, Import, Export, Local Consumption Analysis

5.2.3 China 2012-2017E Hemophilia Drugs Sales Price Analysis

5.2.4 China 2016 Hemophilia Drugs Market Share Analysis

5.3 Europe Hemophilia Drugs Market Analysis

5.3.1 Europe Hemophilia Drugs Market Overview

5.3.2 Europe 2012-2017E Hemophilia Drugs Local Supply, Import, Export, Local Consumption Analysis

5.3.3 Europe 2012-2017E Hemophilia Drugs Sales Price Analysis

5.3.4 Europe 2016 Hemophilia Drugs Market Share Analysis

5.4 Southeast Asia Hemophilia Drugs Market Analysis

5.4.1 Southeast Asia Hemophilia Drugs Market Overview

5.4.2 Southeast Asia 2012-2017E Hemophilia Drugs Local Supply, Import, Export, Local Consumption Analysis

5.4.3 Southeast Asia 2012-2017E Hemophilia Drugs Sales Price Analysis

5.4.4 Southeast Asia 2016 Hemophilia Drugs Market Share Analysis

5.5 Japan Hemophilia Drugs Market Analysis

5.5.1 Japan Hemophilia Drugs Market Overview

5.5.2 Japan 2012-2017E Hemophilia Drugs Local Supply, Import, Export, Local Consumption Analysis

5.5.3 Japan 2012-2017E Hemophilia Drugs Sales Price Analysis

5.5.4 Japan 2016 Hemophilia Drugs Market Share Analysis

5.6 India Hemophilia Drugs Market Analysis

5.6.1 India Hemophilia Drugs Market Overview

5.6.2 India 2012-2017E Hemophilia Drugs Local Supply, Import, Export, Local Consumption Analysis

5.6.3 India 2012-2017E Hemophilia Drugs Sales Price Analysis

5.6.4 India 2016 Hemophilia Drugs Market Share Analysis

6 Global 2012-2017E Hemophilia Drugs Segment Market Analysis (by Type)

6.1 Global 2012-2017E Hemophilia Drugs Sales by Type

6.2 Different Types of Hemophilia Drugs Product Interview Price Analysis

6.3 Different Types of Hemophilia Drugs Product Driving Factors Analysis

6.3.1 Hemophilia A of Hemophilia Drugs Growth Driving Factor Analysis

6.3.2 Hemophilia B of Hemophilia Drugs Growth Driving Factor Analysis

6.3.3 Hemophilia C of Hemophilia Drugs Growth Driving Factor Analysis

7 Global 2012-2017E Hemophilia Drugs Segment Market Analysis (by Application)

7.1 Global 2012-2017E Hemophilia Drugs Consumption by Application

7.2 Different Application of Hemophilia Drugs Product Interview Price Analysis

7.3 Different Application of Hemophilia Drugs Product Driving Factors Analysis

7.3.1 Clinic of Hemophilia Drugs Growth Driving Factor Analysis

7.3.2 Hospital of Hemophilia Drugs Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Hemophilia Drugs

8.1 Baxalta

8.1.1 Company Profile

8.1.2 Product Picture and Specifications

8.1.2.1 Product A

8.1.2.2 Product B

8.1.3 Baxalta 2016 Hemophilia Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.1.4 Baxalta 2016 Hemophilia Drugs Business Region Distribution Analysis

8.2 Bayer

8.2.1 Company Profile

8.2.2 Product Picture and Specifications

8.2.2.1 Product A

8.2.2.2 Product B

8.2.3 Bayer 2016 Hemophilia Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.2.4 Bayer 2016 Hemophilia Drugs Business Region Distribution Analysis

8.3 CSL Behring

8.3.1 Company Profile

8.3.2 Product Picture and Specifications

8.3.2.1 Product A

8.3.2.2 Product B

8.3.3 CSL Behring 2016 Hemophilia Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.3.4 CSL Behring 2016 Hemophilia Drugs Business Region Distribution Analysis

8.4 Novo Nordisk

8.4.1 Company Profile

8.4.2 Product Picture and Specifications

8.4.2.1 Product A

8.4.2.2 Product B

8.4.3 Novo Nordisk 2016 Hemophilia Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.4.4 Novo Nordisk 2016 Hemophilia Drugs Business Region Distribution Analysis

8.5 Pfizer

8.5.1 Company Profile

8.5.2 Product Picture and Specifications

8.5.2.1 Product A

8.5.2.2 Product B

8.5.3 Pfizer 2016 Hemophilia Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.5.4 Pfizer 2016 Hemophilia Drugs Business Region Distribution Analysis

8.6 Roche

8.6.1 Company Profile

8.6.2 Product Picture and Specifications

8.6.2.1 Product A

8.6.2.2 Product B

8.6.3 Roche 2016 Hemophilia Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.6.4 Roche 2016 Hemophilia Drugs Business Region Distribution Analysis

8.7 Alnylam Pharmaceuticals

8.7.1 Company Profile

8.7.2 Product Picture and Specifications

8.7.2.1 Product A

8.7.2.2 Product B

8.7.3 Alnylam Pharmaceuticals 2016 Hemophilia Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.7.4 Alnylam Pharmaceuticals 2016 Hemophilia Drugs Business Region Distribution Analysis

8.8 Amarna Therapeutics

8.8.1 Company Profile

8.8.2 Product Picture and Specifications

8.8.2.1 Product A

8.8.2.2 Product B

8.8.3 Amarna Therapeutics 2016 Hemophilia Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.8.4 Amarna Therapeutics 2016 Hemophilia Drugs Business Region Distribution Analysis

8.9 Asklepios BioPharmaceutical

8.9.1 Company Profile

8.9.2 Product Picture and Specifications

8.9.2.1 Product A

8.9.2.2 Product B

8.9.3 Asklepios BioPharmaceutical 2016 Hemophilia Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.9.4 Asklepios BioPharmaceutical 2016 Hemophilia Drugs Business Region Distribution Analysis

8.10 Biogen

8.10.1 Company Profile

8.10.2 Product Picture and Specifications

8.10.2.1 Product A

8.10.2.2 Product B

8.10.3 Biogen 2016 Hemophilia Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.10.4 Biogen 2016 Hemophilia Drugs Business Region Distribution Analysis

8.11 BioMarin

8.12 Catalyst Bioscience

8.13 Chiesi Farmaceutici

8.14 Dimension Therapeutics

8.15 Emergent BioSolutions

8.16 Grifols, Kedrion Biopharma

8.17 Octapharma

8.18 rEVO Biologics

8.19 OPKO Biologics

8.20 Sangamo Biosciences

8.21 Spark Therapeutics

8.22 Swedish Orphan Biovitrum

8.23 UniQure Biopharma.

9 Development Trend of Analysis of Hemophilia Drugs Market

9.1 Global Hemophilia Drugs Market Trend Analysis

9.1.1 Global 2017-2022 Hemophilia Drugs Market Size (Volume and Value) Forecast

9.1.2 Global 2017-2022 Hemophilia Drugs Sales Price Forecast

9.2 Hemophilia Drugs Regional Market Trend

9.2.1 North America 2017-2022 Hemophilia Drugs Consumption Forecast

9.2.2 China 2017-2022 Hemophilia Drugs Consumption Forecast

9.2.3 Europe 2017-2022 Hemophilia Drugs Consumption Forecast

9.2.4 Southeast Asia 2017-2022 Hemophilia Drugs Consumption Forecast

9.2.5 Japan 2017-2022 Hemophilia Drugs Consumption Forecast

9.2.6 India 2017-2022 Hemophilia Drugs Consumption Forecast

9.3 Hemophilia Drugs Market Trend (Product Type)

9.4 Hemophilia Drugs Market Trend (Application)

10 Hemophilia Drugs Marketing Type Analysis

10.1 Hemophilia Drugs Regional Marketing Type Analysis

10.2 Hemophilia Drugs International Trade Type Analysis

10.3 Traders or Distributors with Contact Information of Hemophilia Drugs by Region

10.4 Hemophilia Drugs Supply Chain Analysis

11 Consumers Analysis of Hemophilia Drugs

11.1 Consumer 1 Analysis

11.2 Consumer 2 Analysis

11.3 Consumer 3 Analysis

11.4 Consumer 4 Analysis

12 Conclusion of the Global Hemophilia Drugs Market Professional Survey Report 2017

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Picture of Hemophilia Drugs

Table Product Specifications of Hemophilia Drugs

Table Classification of Hemophilia Drugs

Figure Global Production Market Share of Hemophilia Drugs by Type in 2016

Figure Hemophilia A Picture

Table Major Manufacturers of Hemophilia A

Figure Hemophilia B Picture

Table Major Manufacturers of Hemophilia B

Figure Hemophilia C Picture

Table Major Manufacturers of Hemophilia C

Table Applications of Hemophilia Drugs

Figure Global Consumption Volume Market Share of Hemophilia Drugs by Application in 2016

Figure Clinic Examples

Table Major Consumers in Clinic

Figure Hospital Examples

Table Major Consumers in Hospital

Figure Market Share of Hemophilia Drugs by Regions

Figure North America Hemophilia Drugs Market Size (Million USD) (2012-2022)

Figure China Hemophilia Drugs Market Size (Million USD) (2012-2022)

Figure Europe Hemophilia Drugs Market Size (Million USD) (2012-2022)

Figure Southeast Asia Hemophilia Drugs Market Size (Million USD) (2012-2022)

Figure Japan Hemophilia Drugs Market Size (Million USD) (2012-2022)

Figure India Hemophilia Drugs Market Size (Million USD) (2012-2022)

Table Hemophilia Drugs Raw Material and Suppliers

Table Manufacturing Cost Structure Analysis of Hemophilia Drugs in 2016

Figure Manufacturing Process Analysis of Hemophilia Drugs

Figure Industry Chain Structure of Hemophilia Drugs

Table Capacity and Commercial Production Date of Global Hemophilia Drugs Major Manufacturers in 2016

Table Manufacturing Plants Distribution of Global Hemophilia Drugs Major Manufacturers in 2016

Table R&D Status and Technology Source of Global Hemophilia Drugs Major Manufacturers in 2016

Table Raw Materials Sources Analysis of Global Hemophilia Drugs Major Manufacturers in 2016

Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Hemophilia Drugs 2012-2017

Figure Global 2012-2017E Hemophilia Drugs Market Size (Volume) and Growth Rate

Figure Global 2012-2017E Hemophilia Drugs Market Size (Value) and Growth Rate

Table 2012-2017E Global Hemophilia Drugs Capacity and Growth Rate

Table 2016 Global Hemophilia Drugs Capacity (K MT) List (Company Segment)

Table 2012-2017E Global Hemophilia Drugs Sales (K MT) and Growth Rate

Table 2016 Global Hemophilia Drugs Sales (K MT) List (Company Segment)

Table 2012-2017E Global Hemophilia Drugs Sales Price (USD/MT)

Table 2016 Global Hemophilia Drugs Sales Price (USD/MT) List (Company Segment)

Figure North America Capacity Overview

Table North America Supply, Import, Export and Consumption (K MT) of Hemophilia Drugs 2012-2017E

Figure North America 2012-2017E Hemophilia Drugs Sales Price (USD/MT)

Figure North America 2016 Hemophilia Drugs Sales Market Share

Figure China Capacity Overview

Table China Supply, Import, Export and Consumption (K MT) of Hemophilia Drugs 2012-2017E

Figure China 2012-2017E Hemophilia Drugs Sales Price (USD/MT)

Figure China 2016 Hemophilia Drugs Sales Market Share

Figure Europe Capacity Overview

Table Europe Supply, Import, Export and Consumption (K MT) of Hemophilia Drugs 2012-2017E

Figure Europe 2012-2017E Hemophilia Drugs Sales Price (USD/MT)

Figure Europe 2016 Hemophilia Drugs Sales Market Share

Figure Southeast Asia Capacity Overview

Table Southeast Asia Supply, Import, Export and Consumption (K MT) of Hemophilia Drugs 2012-2017E

Figure Southeast Asia 2012-2017E Hemophilia Drugs Sales Price (USD/MT)

Figure Southeast Asia 2016 Hemophilia Drugs Sales Market Share

Figure Japan Capacity Overview

Table Japan Supply, Import, Export and Consumption (K MT) of Hemophilia Drugs 2012-2017E

Figure Japan 2012-2017E Hemophilia Drugs Sales Price (USD/MT)

Figure Japan 2016 Hemophilia Drugs Sales Market Share

Figure India Capacity Overview

Table India Supply, Import, Export and Consumption (K MT) of Hemophilia Drugs 2012-2017E

Figure India 2012-2017E Hemophilia Drugs Sales Price (USD/MT)

Figure India 2016 Hemophilia Drugs Sales Market Share

Table Global 2012-2017E Hemophilia Drugs Sales (K MT) by Type

Table Different Types Hemophilia Drugs Product Interview Price

Table Global 2012-2017E Hemophilia Drugs Sales (K MT) by Application

Table Different Application Hemophilia Drugs Product Interview Price

Table Baxalta Information List

Table Product A Overview

Table Product B Overview

Table 2016 Baxalta Hemophilia Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)

Figure 2016 Baxalta Hemophilia Drugs Business Region Distribution

Table Bayer Information List

Table Product A Overview

Table Product B Overview

Table 2016 Bayer Hemophilia Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)

Figure 2016 Bayer Hemophilia Drugs Business Region Distribution

Table CSL Behring Information List

Table Product A Overview

Table Product B Overview

Table 2015 CSL Behring Hemophilia Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)

Figure 2016 CSL Behring Hemophilia Drugs Business Region Distribution

Table Novo Nordisk Information List

Table Product A Overview

Table Product B Overview

Table 2016 Novo Nordisk Hemophilia Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)

Figure 2016 Novo Nordisk Hemophilia Drugs Business Region Distribution

Table Pfizer Information List

Table Product A Overview

Table Product B Overview

Table 2016 Pfizer Hemophilia Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)

Figure 2016 Pfizer Hemophilia Drugs Business Region Distribution

Table Roche Information List

Table Product A Overview

Table Product B Overview

Table 2016 Roche Hemophilia Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)

Figure 2016 Roche Hemophilia Drugs Business Region Distribution

Table Alnylam Pharmaceuticals Information List

Table Product A Overview

Table Product B Overview

Table 2016 Alnylam Pharmaceuticals Hemophilia Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)

Figure 2016 Alnylam Pharmaceuticals Hemophilia Drugs Business Region Distribution

Table Amarna Therapeutics Information List

Table Product A Overview

Table Product B Overview

Table 2016 Amarna Therapeutics Hemophilia Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)

Figure 2016 Amarna Therapeutics Hemophilia Drugs Business Region Distribution

Table Asklepios BioPharmaceutical Information List

Table Product A Overview

Table Product B Overview

Table 2016 Asklepios BioPharmaceutical Hemophilia Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)

Figure 2016 Asklepios BioPharmaceutical Hemophilia Drugs Business Region Distribution

Table Biogen Information List

Table Product A Overview

Table Product B Overview

Table 2016 Biogen Hemophilia Drugs Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)

Figure 2016 Biogen Hemophilia Drugs Business Region Distribution

Table BioMarin Information List

Table Catalyst Bioscience Information List

Table Chiesi Farmaceutici Information List

Table Dimension Therapeutics Information List

Table Emergent BioSolutions Information List

Table Grifols, Kedrion Biopharma Information List

Table Octapharma Information List

Table rEVO Biologics Information List

Table OPKO Biologics Information List

Table Sangamo Biosciences Information List

Table Spark Therapeutics Information List

Table Swedish Orphan Biovitrum Information List

Table UniQure Biopharma. Information List

Figure Global 2017-2022 Hemophilia Drugs Market Size (K MT) and Growth Rate Forecast

Figure Global 2017-2022 Hemophilia Drugs Market Size (Million USD) and Growth Rate Forecast

Figure Global 2017-2022 Hemophilia Drugs Sales Price (USD/MT) Forecast

Figure North America 2017-2022 Hemophilia Drugs Consumption Volume (K MT) and Growth Rate Forecast

Figure China 2017-2022 Hemophilia Drugs Consumption Volume (K MT) and Growth Rate Forecast

Figure Europe 2017-2022 Hemophilia Drugs Consumption Volume (K MT) and Growth Rate Forecast

Figure Southeast Asia 2017-2022 Hemophilia Drugs Consumption Volume (K MT) and Growth Rate Forecast

Figure Japan 2017-2022 Hemophilia Drugs Consumption Volume (K MT) and Growth Rate Forecast

Figure India 2017-2022 Hemophilia Drugs Consumption Volume (K MT) and Growth Rate Forecast

Table Global Sales Volume (K MT) of Hemophilia Drugs by Type 2017-2022

Table Global Consumption Volume (K MT) of Hemophilia Drugs by Application 2017-2022

Table Traders or Distributors with Contact Information of Hemophilia Drugs by Region

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370